Drug Trial Radar · NCT07460986
A Phase Ib/II Study to Evaluate Safety and Efficacy of Bexmarilimab in Combination With Doxorubicin in Metastatic Soft-tissue Sarcoma.
Last checked: Nov 19, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
278
Planned (sponsor's estimate)
Start
Aug 20, 2026
Primary completion
Jul 2028
Study completion Oct 2028
Sponsor
- Lead sponsor
- MedSIRAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Faron Pharmaceuticals Ltd
- First posted
- Mar 10, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial will Study a type of sarcoma defined metastatic soft-tissue sarcoma (STS). Participants will be treated with bexmarilimab, a CLEVER-1 antibody plus doxorubicin, a chemotherapy. The main purpose of the Study is to analyze the safety (to find out how safe or toxic a treatment is to appropriately manage the risks) and efficacy (to find out how effective a treatment is) of bexmarilimab combined with doxorubicin in participants who have STS.
Conditions
- Soft Tissue Sarcoma (STS)
Interventions
bexmarilimabDrug
RP2D of bexmarilimab administered as IV infusion on D1 of 21-day cycle for 6 cycles.
DoxorubicinDrug
75 mg/m2 doxorubicin administered as IV infusion on D1 of 21-day cycle for 6 cycles.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase Ib: MTD and RP2DTime frame: Up to 14 months
- Phase II: PFSTime frame: Up to 36 months
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Institut Català d' Oncologia Badalona (ICO)
Badalona, Spain · Not yet recruiting
Hospital de Cruces
Barakaldo, Spain · Not yet recruiting
Hospital Universitari Vall D'Hebron (VHIO)
Barcelona, Spain · Recruiting
Hospital Clínico San Carlos
Madrid, Spain · Recruiting
Hospital Universitario Doce de Octubre
Madrid, Spain · Recruiting
Hospital Universitario Gregorio Marañón
Madrid, Spain · Not yet recruiting
Hospital Universitario La Paz
Madrid, Spain · Not yet recruiting
Hospital Universitario Virgen de la Victoria
Málaga, Spain · Recruiting
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Spain · Not yet recruiting
Hospital Universitario Virgen del Rocío
Seville, Spain · Not yet recruiting
Hospital Universitario Miguel Servet
Zaragoza, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.